HUT75717A - Nucleic acid molecules encoding cytoplasmatic alcohol dehydrogenase and glutamil-cystein synthetase, vectors to introduce them and processes employing these vectors - Google Patents

Nucleic acid molecules encoding cytoplasmatic alcohol dehydrogenase and glutamil-cystein synthetase, vectors to introduce them and processes employing these vectors

Info

Publication number
HUT75717A
HUT75717A HU9403377A HU9403377A HUT75717A HU T75717 A HUT75717 A HU T75717A HU 9403377 A HU9403377 A HU 9403377A HU 9403377 A HU9403377 A HU 9403377A HU T75717 A HUT75717 A HU T75717A
Authority
HU
Hungary
Prior art keywords
vectors
glutamil
cytoplasmatic
cystein
synthetase
Prior art date
Application number
HU9403377A
Other languages
English (en)
Other versions
HU9403377D0 (en
Inventor
Riccardo Dalla-Favera
Alessandro Massimo Gianni
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of HU9403377D0 publication Critical patent/HU9403377D0/hu
Publication of HUT75717A publication Critical patent/HUT75717A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01003—Aldehyde dehydrogenase (NAD+) (1.2.1.3)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HU9403377A 1993-04-01 1994-04-01 Nucleic acid molecules encoding cytoplasmatic alcohol dehydrogenase and glutamil-cystein synthetase, vectors to introduce them and processes employing these vectors HUT75717A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4172293A 1993-04-01 1993-04-01

Publications (2)

Publication Number Publication Date
HU9403377D0 HU9403377D0 (en) 1995-02-28
HUT75717A true HUT75717A (en) 1997-05-28

Family

ID=21917990

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9403377A HUT75717A (en) 1993-04-01 1994-04-01 Nucleic acid molecules encoding cytoplasmatic alcohol dehydrogenase and glutamil-cystein synthetase, vectors to introduce them and processes employing these vectors

Country Status (14)

Country Link
US (2) US5888820A (hu)
EP (1) EP0648261A4 (hu)
JP (1) JPH08501221A (hu)
KR (1) KR950701969A (hu)
CN (1) CN1109260A (hu)
AU (1) AU6623994A (hu)
CA (1) CA2135912A1 (hu)
FI (1) FI945665A0 (hu)
HU (1) HUT75717A (hu)
IL (1) IL109168A0 (hu)
NZ (1) NZ265472A (hu)
PL (1) PL306549A1 (hu)
RU (1) RU94046095A (hu)
WO (1) WO1994023015A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109168A0 (en) 1993-04-01 1994-06-24 Univ Columbia A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs
JPH08508888A (ja) * 1993-04-08 1996-09-24 コーネル・リサーチ・ファウンデーション，インコーポレイテッド グルタミルシステイン・シンセターゼ軽サブユニット
CN1078613C (zh) * 1997-12-25 2002-01-30 中国科学院遗传研究所 山菠菜甜菜碱醛脱氢酶基因以及提高植物耐盐性的方法
WO2000023606A1 (en) 1998-10-22 2000-04-27 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
MY142328A (en) * 2002-03-26 2010-11-15 Ajinomoto Kk CANDIDA UTILIS CONTAINING y-GLUTAMYLCYSTEINE
WO2007065167A1 (en) * 2005-12-02 2007-06-07 The Johns Hopkins University Use of high-dose oxazaphosphorine drugs for treating immune disorders
WO2008034074A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2008034076A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclophosphamide in combination with immune therapeutics
WO2008034071A2 (en) * 2006-09-15 2008-03-20 The Johns Hopkins University Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2009067690A2 (en) * 2007-11-21 2009-05-28 Accentia Biopharmaceuticals, Inc. Methods for safe and effective treatment using oxazaphosphorine drugs
US9026372B2 (en) * 2007-11-21 2015-05-05 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
BR112012032991B1 (pt) * 2010-06-22 2021-08-10 Regeneron Pharmaceuticals, Inc Método para preparar um anticorpo que se liga a um antígeno de interesse
KR102434557B1 (ko) * 2010-08-02 2022-08-23 리제너론 파아마슈티컬스, 인크. Ｖｌ 도메인을 포함하는 결합 단백질을 생성하는 마우스
CN111417407A (zh) * 2017-11-15 2020-07-14 奇异科学有限责任公司 用于非清髓性骨髓重建的方法和组合物
MX2021000421A (es) 2018-07-15 2021-05-12 Enochian Biopharma Inc Métodos y composiciones que usan células dendríticas recombinantes para el tratamiento del cáncer.
EP4096649A4 (en) * 2020-01-31 2024-04-17 G Tech Bio Llc COMPOSITIONS AND METHODS FOR PROVIDING CHEMOPROTECTIVE EFFECTS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
AU3969993A (en) * 1992-04-01 1993-11-08 Cornell Research Foundation Inc. Method and recombinant cells for providing increased resistance of hematopoietic progenitor cells to toxicity of chemotherapeutic agents
IL109168A0 (en) 1993-04-01 1994-06-24 Univ Columbia A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs

Also Published As

Publication number Publication date
CA2135912A1 (en) 1994-10-13
US5888820A (en) 1999-03-30
RU94046095A (ru) 1997-03-27
FI945665A (fi) 1994-12-01
EP0648261A4 (en) 1997-10-22
US6268138B1 (en) 2001-07-31
AU6623994A (en) 1994-10-24
PL306549A1 (en) 1995-04-03
WO1994023015A1 (en) 1994-10-13
IL109168A0 (en) 1994-06-24
HU9403377D0 (en) 1995-02-28
JPH08501221A (ja) 1996-02-13
NZ265472A (en) 1996-10-28
KR950701969A (ko) 1995-05-17
CN1109260A (zh) 1995-09-27
EP0648261A1 (en) 1995-04-19
FI945665A0 (fi) 1994-12-01

Similar Documents

Publication Publication Date Title
HUT75717A (en) Nucleic acid molecules encoding cytoplasmatic alcohol dehydrogenase and glutamil-cystein synthetase, vectors to introduce them and processes employing these vectors
WO1995006731A3 (en) Non-nucleotide containing enzymatic nucleic acid
HRP940175A2 (en) Nucleic acid pharmaceuticals
EP1032656A4 (en) ISOLATED NUCLEIC ACID MOLECULE ENCODING MAMMALIAN ENDOGLUCURONIDASE AND ITS APPLICATIONS
AU8095594A (en) Dna encoding triol polyketide synthase
CA2343880A1 (en) Polyketide synthase enzymes and recombinant dna constructs therefor
EP0585109A3 (en) N-acetylglucosaminyl transferase, gene coding therefor, corresponding vectors and transformed hosts, processes for production thereof
WO1998021343A8 (en) Genes encoding telomerase proteins
CA2153254A1 (en) Cloning of enterokinase and method of use
AU6589094A (en) 7-deazapurine modified oligonucleotides
WO2000018914A3 (en) Novel dkr polypeptides
EP0820523A4 (en) PRESERVED NUCLEIC ACID SEQUENCES OF YEAST
EP0659464A3 (en) Production of nitrogen using membranes with temperature monitoring.
EP0760849A4 (en) RECOMBINANT BACTERICIDAL PERMEABILITY (BPI) AND LIPOSACCHARIDE (LBD) RECOMBINANT PROTEINS, MOLECULES ENCODING THE SAME, THEIR PRODUCTION METHODS AND THEIR USES
AU2635397A (en) Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants
ZA948987B (en) Therapy
IL162477A0 (en) Nucleic acid molecules encoding delta-5,7-sterol, delta-7 reductase from arabidopsis thaliana
AU6092394A (en) Amplification of nucleic acid sequences
EP0677581A4 (en) DNA WHICH CODES THE PLANT-BASED ATP-DEPENDENT FRUCTOSE-6-PHOSPHATE-1-PHOSPHOTRANSFERASE, A RECOMBINANT VECTOR CONTAINING THE SAME, AND A METHOD FOR CHANGING THE SUGAR CONTENT OF A PLANT PLANT THROUGH PLANT.
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
AU4390099A (en) Nucleotide sequences of the apple lrpkm1 gene, encoded amino acid sequence and uses thereof
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
WO1999036432A3 (de) Orotidin-5'-phosphatdecarboxylase-gen, genkonstrukt enthaltend dieses gen und seine verwendung
AU8132994A (en) Nucleic acids encoding {his5, trp7, tyr8}-gnrh preprohormone and {ser8}-gnrh preprohormone and their uses

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee